Question 1

Has Leslie Tharenos received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $2,322,500 in general payments to Leslie Tharenos across 316 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Leslie Tharenos did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Leslie Tharenos come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Janssen Research & Development, LLC	24	$638,968
Sanofi Pasteur Inc.	51	$455,996
Merck	4	$320,466
Kowa Research Institute, Inc.	66	$207,416
Emergent Biosolutions Inc.	11	$198,247
Takeda Pharmaceuticals U.S.A., Inc.	18	$143,882
Novartis	4	$128,730
Vertex	4	$123,692
AbbVie	56	$64,030
AstraZeneca	1	$32,525
Alnylam Pharmaceuticals Inc.	69	$4,044
Teva Pharmaceuticals USA, Inc.	1	$2,300
Bavarian Nordic A/s	2	$1,300
Regeneron	2	$875
Novo Nordisk AS	3	$29

Leslie Tharenos

Payments from drug & device makers

Who reported the general payments

How this compares

Other preventive medicine/occupational environmental medicine in Saint Louis